Detalles de la búsqueda
1.
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.
Blood
; 118(11): 3096-106, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21719597
2.
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
Breast Cancer Res Treat
; 135(2): 433-44, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22825030
3.
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.
ACS Chem Biol
; 11(11): 3214-3225, 2016 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27552339
4.
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.
Oncotarget
; 3(11): 1416-27, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23232026
5.
Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
Mol Cancer Ther
; 11(4): 973-83, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22367781
6.
Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Mol Cancer Ther
; 10(7): 1194-206, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21566061
7.
Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells.
Clin Cancer Res
; 17(23): 7347-58, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976548
Resultados
1 -
7
de 7
1
Próxima >
>>